Literature DB >> 3009901

Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma.

T Matsukura, T Kanda, A Furuno, H Yoshikawa, T Kawana, K Yoshiike.   

Abstract

We have molecularly cloned and characterized monomeric human papillomavirus type 16 DNA with flanking cell DNA sequences from a cervical carcinoma. Determination of nucleotide sequence around the junctions of human papillomavirus and cell DNAs revealed that at the site of integration within cell DNA the cloned viral DNA had a deletion between nucleotides 1,284 and 4,471 (numbering system from K. Seedorf, G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwekamp, Virology 145:181-185, 1985), which includes the greater part of E1 gene and the entire E2 gene. In the remaining part of the E1 gene, three guanines were found at the location where two guanines at nucleotides 1,137 and 1,138 have been recorded. This additional guanine shifted the reading frame and erased an interruption in the E1 gene described by Seedorf et al. The data strongly suggest that, like other papillomaviruses, human papillomavirus type 16 has an uninterrupted E1 gene.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3009901      PMCID： PMC253011     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Partial characterization of viral DNA from human genital warts (Condylomata acuminata).

Authors:  L Gissmann; H zur Hausen
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

4.  The primary structure and genetic organization of the bovine papillomavirus type 1 genome.

Authors:  E Y Chen; P M Howley; A D Levinson; P H Seeburg
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

5.  Ubiquitous, interspersed repeated sequences in mammalian genomes.

Authors:  W R Jelinek; T P Toomey; L Leinwand; C H Duncan; P A Biro; P V Choudary; S M Weissman; C M Rubin; C M Houck; P L Deininger; C W Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some.

Authors:  F O Wettstein; J G Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas.

Authors:  H Yoshikawa; T Matsukura; E Yamamoto; T Kawana; M Mizuno; K Yoshiike
Journal:  Jpn J Cancer Res       Date:  1985-08

9.  Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.

Authors:  L Gissmann; L Wolnik; H Ikenberg; U Koldovsky; H G Schnürch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205
View more
  37 in total

1.  Progression of the phenotype of transformed cells after growth stimulation of cells by a human papillomavirus type 16 gene function.

Authors:  T Noda; H Yajima; Y Ito
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas.

Authors:  H Shirasawa; Y Tomita; K Kubota; T Kasai; S Sekiya; H Takamizawa; B Simizu
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 3.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers.

Authors:  C P Crum; G Nuovo; D Friedman; S J Silverstein
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells.

Authors:  T Kanda; A Furuno; K Yoshiike
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

6.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses.

Authors:  S H Tan; D Bartsch; E Schwarz; H U Bernard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

Authors:  M T Chin; T R Broker; L T Chow
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

9.  Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias.

Authors:  Y Fujinaga; K Okazawa; A Nishikawa; Y Yamakawa; M Fukushima; I Kato; K Fujinaga
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

10.  Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33.

Authors:  M Evander; E Bodén; L Bjersing; E Rylander; G Wadell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.